Cargando…
Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
The pandemic spread of a novel coronavirus – SARS coronavirus-2 (SARS-CoV-2) as a cause of acute respiratory illness, named Covid-19, is placing the healthcare systems of many countries under unprecedented stress. Global economies are also spiraling towards a recession in fear of this new life-threa...
Autores principales: | de Alwis, Ruklanthi, Chen, Shiwei, Gan, Esther S., Ooi, Eng Eong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161485/ https://www.ncbi.nlm.nih.gov/pubmed/32344202 http://dx.doi.org/10.1016/j.ebiom.2020.102768 |
Ejemplares similares
-
Herd immunity: hyperimmune globulins for the 21st century
por: Elliott, Sarah TC, et al.
Publicado: (2018) -
Hyperimmune Globulins for the Management of Infectious Diseases
por: Pati, Ilaria, et al.
Publicado: (2023) -
GAMMA GLOBULIN TURNOVER IN RABBITS BEFORE AND DURING HYPERIMMUNIZATION
por: Andersen, Stig Bryde, et al.
Publicado: (1964) -
Biweekly Versus Monthly Hyperimmune Globulin Therapy for Primary Cytomegalovirus Infection in Pregnancy
por: Schirwani-Hartl, Nawa, et al.
Publicado: (2023) -
Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccine
por: Tschismarov, Roland, et al.
Publicado: (2021)